Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears 
Finnair Orders 18 Embraer E195-E2 Jets in Landmark Fleet Overhaul 
Asian Stocks Gain Amid Iran Conflict Uncertainty 
Iran-Israel Missile Strikes Continue Amid Mixed Signals on U.S.-Iran Diplomacy 
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 
Asian Currencies Weaken as Dollar Rebounds Amid Middle East Uncertainty and Japan Inflation Data 
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty 
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis 
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
Oil Prices Rebound as Iran Denies U.S. Talks Amid Gulf War Supply Fears 
SLMG Beverages Eyes Price Hikes Amid Rising Packaging Costs and India's Booming Soft Drink Market 
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Australia's Inflation Eases in February but Core Pressures Persist 
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 
Berkshire Hathaway and Tokio Marine Form Major Strategic Insurance Partnership 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
